Assessing other immune cells in the lungs, we detected a significant increase in the accumulation of T-cells, neutrophils and NK cells after CCR1 inhibition at d21 compared with the respective controls (Figs. 6D, S5), indicating a shift towards a pro-inflammatory tumour microenvironment in this group. Here, CCR1 is linked to neoplasm.